Transrectal Ultrasound Market Size, Share & Demand Report By Type (Biplane Transrectal Ultrasound Systems, End-Fire Transrectal Ultrasound Systems, 3D/4D Transrectal Ultrasound Systems), By Application (Prostate Cancer Diagnosis, Prostate Biopsy Guidance, Prostate Volume Measurement, Other Urological Applications), By End Use (Hospitals, Diagnostic Imaging Centers, Specialty Clinics), By Region & Segment Forecasts, 2025–2034

Key Highlights

• North America held the dominant regional share of 38% in 2025, while Asia Pacific is projected to grow fastest at a CAGR of 7.2%.
• Biplane transrectal ultrasound systems accounted for the largest share of the type segment (56%), while 3D/4D imaging systems are expected to grow fastest at 7.8% CAGR.
• Prostate cancer diagnosis dominated the application segment with 48% share, while prostate biopsy guidance will expand fastest at 7.5% CAGR.
• The United States led the market, with a value of USD 150 million in 2025 and an estimated USD 158 million in 2026.

Market Trends 

Integration of Advanced Imaging Technologies

A significant trend influencing the Transrectal Ultrasound Market is the integration of advanced imaging technologies such as 3D and 4D ultrasound imaging. These technologies provide enhanced visualization of prostate anatomy and improve diagnostic accuracy during prostate biopsy procedures. Compared with conventional two-dimensional systems, advanced imaging allows physicians to precisely identify suspicious lesions and guide biopsy needles with higher accuracy. Healthcare facilities are increasingly upgrading existing equipment to include these capabilities. As medical imaging technology continues to evolve, manufacturers are focusing on improving image resolution, probe sensitivity, and real-time visualization, which is expected to strengthen clinical adoption.

Growing Use of Image-Guided Biopsy Procedures

Another notable trend shaping the Transrectal Ultrasound Market is the increasing adoption of ultrasound-guided biopsy procedures. TRUS systems are widely used to guide prostate biopsies, ensuring accurate tissue sampling while minimizing procedural complications. The growing emphasis on minimally invasive diagnostic procedures has supported the adoption of image-guided technologies in urology. Hospitals and specialty clinics are integrating TRUS systems with biopsy guidance software and navigation tools, improving workflow efficiency and diagnostic confidence. This trend is expected to continue as healthcare providers seek imaging solutions that combine precision, real-time guidance, and improved patient outcomes.

Market Drivers 

Rising Prevalence of Prostate Disorders

One of the primary drivers of the Transrectal Ultrasound Market is the increasing prevalence of prostate disorders worldwide. Conditions such as prostate cancer, prostatitis, and benign prostatic hyperplasia are becoming more common, particularly among aging male populations. As life expectancy rises globally, the number of individuals requiring prostate diagnostic procedures is also increasing. Transrectal ultrasound provides a reliable and widely accessible imaging technique for evaluating prostate abnormalities. Its ability to provide real-time imaging during biopsy procedures makes it an essential diagnostic tool in urology practices. The growing patient population requiring prostate screening and diagnosis will continue to support steady demand for TRUS systems.

Expansion of Diagnostic Imaging Infrastructure

Another key driver supporting market growth is the expansion of diagnostic imaging infrastructure across healthcare systems. Governments and healthcare organizations are investing in advanced medical imaging equipment to strengthen early disease detection capabilities. Hospitals, diagnostic centers, and specialized urology clinics are expanding imaging services to meet growing patient demand. The relatively lower cost of ultrasound systems compared with other imaging modalities makes TRUS devices an attractive investment for healthcare providers. As healthcare infrastructure continues to expand, particularly in emerging economies, the adoption of transrectal ultrasound technology will increase.

Market Restraint

Patient Discomfort and Procedure Limitations

Despite its clinical value, the Transrectal Ultrasound Market faces limitations related to patient discomfort and procedural constraints. The transrectal approach used during TRUS examinations can cause discomfort or anxiety for some patients, which may affect willingness to undergo the procedure. Additionally, in certain cases, physicians may require complementary imaging techniques such as magnetic resonance imaging (MRI) to confirm diagnosis or identify suspicious lesions more precisely.

The procedure also requires skilled healthcare professionals to operate the equipment and interpret imaging results accurately. Limited availability of trained specialists in some healthcare settings can reduce the utilization of TRUS technology. Furthermore, improvements in alternative imaging methods, including MRI-based prostate imaging, may reduce reliance on conventional ultrasound diagnostics in certain clinical scenarios.

These factors can limit the adoption of transrectal ultrasound systems in some healthcare environments. However, ongoing improvements in probe design, imaging quality, and patient comfort technologies are expected to gradually address these limitations and support continued use of TRUS in clinical diagnostics.

Market Opportunities 

Development of AI-Assisted Imaging Systems

Artificial intelligence integration presents a significant opportunity in the Transrectal Ultrasound Market. AI-powered imaging software can assist physicians in identifying suspicious lesions and improving diagnostic accuracy during ultrasound examinations. Machine learning algorithms can analyze imaging data to highlight potential abnormalities and support clinical decision-making. As AI technologies become more integrated into medical imaging devices, manufacturers have opportunities to develop advanced TRUS systems with automated image interpretation and enhanced workflow efficiency.

Growing Healthcare Investments in Emerging Economies

Emerging economies are experiencing rapid expansion in healthcare infrastructure, creating new opportunities for the Transrectal Ultrasound Market. Countries in Asia Pacific, Latin America, and parts of the Middle East are increasing investments in diagnostic imaging equipment to strengthen early disease detection capabilities. Growing healthcare spending, rising awareness of prostate health, and expansion of hospital networks are encouraging the adoption of ultrasound technologies. Manufacturers that establish distribution networks and local partnerships in these regions may benefit from increased equipment demand and expanding patient populations.

Segmental Analysis 

By Type

Biplane transrectal ultrasound systems dominated the Transrectal Ultrasound Market in 2025 and accounted for 56% of the total market share. These systems provide both sagittal and transverse imaging views, enabling physicians to evaluate prostate anatomy with greater accuracy. The ability to visualize multiple imaging planes during diagnostic procedures supported widespread use of biplane systems in hospitals and urology clinics. Their compatibility with biopsy guidance devices also made them the preferred choice for prostate biopsy procedures.

The 3D/4D transrectal ultrasound systems segment will grow at the fastest CAGR of 7.8% during the forecast period. These systems will gain adoption due to their ability to provide detailed volumetric imaging of prostate tissues. Advanced imaging capabilities allow physicians to identify suspicious lesions and guide biopsy needles more precisely. As healthcare providers continue to upgrade diagnostic imaging equipment, demand for advanced 3D and 4D ultrasound technologies will increase.

By Application

Prostate cancer diagnosis represented the dominant application segment in 2025 with a 48% share of the Transrectal Ultrasound Market. TRUS systems play a crucial role in evaluating prostate abnormalities and supporting early detection of prostate cancer. Healthcare providers frequently use ultrasound imaging to visualize prostate structures and assess suspicious lesions before biopsy procedures. The growing emphasis on early cancer detection programs contributed to strong demand for ultrasound imaging in this application.

The prostate biopsy guidance segment will expand at a CAGR of 7.5% during the forecast period. TRUS-guided biopsy procedures will become more common as physicians focus on improving diagnostic accuracy. Real-time imaging provided by ultrasound technology will allow clinicians to guide biopsy needles with precision and obtain representative tissue samples. Integration of navigation software and imaging enhancements will further support growth in this segment.

By End Use

Hospitals held the largest share of the Transrectal Ultrasound Market in 2025 at 52%. Large healthcare institutions typically manage high patient volumes and perform complex diagnostic procedures, which supports demand for advanced imaging equipment. Hospitals also maintain specialized urology departments equipped with ultrasound systems for prostate evaluation and biopsy procedures. Continuous equipment upgrades and replacement cycles contributed to the strong market presence of hospitals.

Diagnostic imaging centers will grow at the fastest CAGR of 7.1% during the forecast period. These facilities will expand due to the growing demand for specialized diagnostic services. Imaging centers often focus on providing cost-effective and efficient diagnostic procedures, attracting patients referred by hospitals and clinics. As healthcare systems emphasize early detection and outpatient diagnostic services, imaging centers will increasingly adopt transrectal ultrasound systems.

Regional Analysis 

North America

North America accounted for 38% of the global Transrectal Ultrasound Market share in 2025 and will expand at a CAGR of 5.4% during 2025–2034. The region maintained a strong presence due to advanced healthcare infrastructure, widespread adoption of diagnostic imaging technologies, and high awareness regarding prostate health screening. Hospitals and specialty urology clinics in the region routinely use transrectal ultrasound systems for prostate evaluation and biopsy procedures. The presence of established medical device manufacturers and frequent product upgrades supported steady equipment replacement cycles across healthcare facilities.

The United States represented the dominant country in the region. One major growth factor has been the strong adoption of early prostate cancer detection programs supported by healthcare providers and public health initiatives. Screening campaigns and improved insurance coverage for diagnostic procedures encouraged routine prostate examinations among aging male populations. Healthcare institutions across the country also adopted advanced ultrasound imaging systems to improve biopsy accuracy and patient management, contributing to stable demand for TRUS equipment.

Europe

Europe represented 27% of the global Transrectal Ultrasound Market in 2025 and will grow at a CAGR of 5.2% during the forecast period. The region demonstrated consistent adoption of ultrasound-based diagnostic technologies due to well-established healthcare systems and increasing attention to cancer screening programs. Hospitals across Western Europe have implemented standardized prostate screening protocols, which include transrectal ultrasound examinations during biopsy procedures. Demand for high-resolution ultrasound equipment also increased as healthcare providers sought improved imaging capabilities.

Germany remained the dominant country within the European market. A notable growth factor has been the expansion of specialized urology clinics and diagnostic imaging centers. These facilities increasingly adopted modern ultrasound platforms to support prostate imaging and biopsy procedures. The country’s strong medical technology sector and investment in hospital modernization also contributed to the continued adoption of advanced diagnostic imaging systems, including transrectal ultrasound devices.

Asia Pacific

Asia Pacific accounted for 21% of the Transrectal Ultrasound Market share in 2025 and is expected to grow at the fastest CAGR of 7.2% through 2034. Rapid healthcare infrastructure development and increasing awareness of prostate health have strengthened demand for diagnostic imaging technologies across the region. Governments in several countries have increased investments in hospital equipment and diagnostic services to improve disease detection rates.

China represented the leading country in the Asia Pacific region. A major growth factor has been the rapid expansion of hospital networks and diagnostic imaging departments. Urban healthcare institutions are increasingly adopting advanced ultrasound equipment to support early detection of urological disorders. Rising healthcare expenditure and expanding access to medical services in urban and semi-urban areas have encouraged the adoption of transrectal ultrasound systems in hospitals and diagnostic centers.

Middle East & Africa

The Middle East & Africa held approximately 8% of the global Transrectal Ultrasound Market in 2025 and will grow at a CAGR of 5.6% during the forecast period. Healthcare modernization programs across several countries in the region have supported the adoption of advanced diagnostic equipment. Governments have focused on strengthening hospital infrastructure and improving access to medical imaging technologies.

Saudi Arabia emerged as the dominant country in the regional market. A key growth factor has been increased government investment in healthcare infrastructure development. The expansion of public hospitals and specialized medical centers has created demand for modern diagnostic equipment, including ultrasound imaging systems. Healthcare providers in the country are gradually integrating advanced diagnostic technologies to improve patient care and support early disease detection initiatives.

Latin America

Latin America accounted for 6% of the Transrectal Ultrasound Market share in 2025 and is projected to grow at a CAGR of 5.8% through 2034. The region’s healthcare sector has been gradually adopting modern imaging technologies as governments focus on improving diagnostic capabilities. Expanding hospital infrastructure and rising awareness regarding prostate health screening are supporting demand for transrectal ultrasound equipment.

Brazil represented the leading country in the regional market. A major growth factor has been the expansion of private healthcare networks and diagnostic laboratories. These institutions increasingly invest in imaging equipment to strengthen diagnostic services and attract patient volumes. The availability of specialized urology services within urban healthcare facilities has further supported adoption of transrectal ultrasound technology.

Competitive Landscape

The Transrectal Ultrasound Market is moderately consolidated, with several global medical imaging companies competing through product innovation, imaging technology improvements, and geographic expansion. Leading manufacturers focus on improving ultrasound imaging resolution, integrating advanced biopsy guidance tools, and expanding product portfolios to address clinical needs in urology diagnostics.

GE HealthCare remained one of the leading companies in the market due to its extensive ultrasound technology portfolio and global distribution network. The company continues to introduce advanced imaging systems designed for improved diagnostic precision and workflow efficiency.

Other key players including Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, and Fujifilm Holdings Corporation are actively investing in product development and imaging software enhancements. Strategic partnerships with healthcare institutions and expansion into emerging markets are common strategies among market participants aiming to strengthen their presence in the transrectal ultrasound industry.

Key Players 

1. GE HealthCare
2. Siemens Healthineers
3. Koninklijke Philips N.V.
4. Canon Medical Systems Corporation
5. Fujifilm Holdings Corporation
6. Samsung Medison Co., Ltd.
7. Mindray Medical International Limited
8. Hitachi Medical Systems
9. BK Medical Holding Company, Inc.
10. Esaote S.p.A.
11. Shenzhen SonoScape Medical Corp.
12. EDAN Instruments, Inc.
13. Alpinion Medical Systems Co., Ltd.
14. Analogic Corporation
15. Chison Medical Technologies Co., Ltd.

Recent Developments

• In 2024, GE HealthCare introduced a new ultrasound imaging platform designed to improve prostate imaging workflows in urology practices.
• In 2023, Siemens Healthineers expanded its ultrasound portfolio with systems supporting advanced imaging and biopsy guidance capabilities.
• In 2023, Canon Medical Systems launched upgraded ultrasound probes with improved imaging sensitivity for urological diagnostics.
• In 2024, Mindray expanded its ultrasound product distribution across emerging markets to strengthen access to diagnostic imaging technologies.